
Sorcero is a life sciences AI platform that transforms complex data into actionable insights for Medical Affairs, Safety, and SciComms teams. Their Sorcero Intelligence Platform, including products like Sorcero Medical, Sorcero Safety, and Sorcero SciComms, helps companies accelerate evidence generation, monitor safety signals, and improve scientific communication. Key features include the Sorcero Instant Insights Engine, which provides AI-driven answers to complex medical questions, and capabilities for systematic literature reviews and plain language summaries. Sorcero aims to optimize time-consuming tasks and drive data-driven decisions to improve patient outcomes and accelerate patient access to therapies. The company has been recognized as one of the world's most innovative companies.

Sorcero is a life sciences AI platform that transforms complex data into actionable insights for Medical Affairs, Safety, and SciComms teams. Their Sorcero Intelligence Platform, including products like Sorcero Medical, Sorcero Safety, and Sorcero SciComms, helps companies accelerate evidence generation, monitor safety signals, and improve scientific communication. Key features include the Sorcero Instant Insights Engine, which provides AI-driven answers to complex medical questions, and capabilities for systematic literature reviews and plain language summaries. Sorcero aims to optimize time-consuming tasks and drive data-driven decisions to improve patient outcomes and accelerate patient access to therapies. The company has been recognized as one of the world's most innovative companies.
Sector: Life sciences AI / medical language intelligence
Headquarters (city): Washington, D.C.
Founded: 2018
Notable products: Sorcero Intelligence Platform (Sorcero Medical, Safety, SciComms, MedTech)
Recent funding signal: Series B announced ($42.5M) and prior Series A $10M (2021)
Managing and extracting actionable insights from large volumes of scientific and clinical literature for medical affairs, safety monitoring, and scientific communication.
2018
Life sciences / Healthcare AI
10,000,000.00
Series A announced Sept 16, 2021; reporting indicates $10M Series A and total funding reported around $15.7M at that time.
Pre-seed round announced Nov 23, 2018.
42,500,000.00
Company press release announcing a $42.5M Series B financing.